| Selinexor Monotherapy for Cytoreduction in BCR::ABL1-Negative Myeloproliferative Neoplasms (NCT07626021) | Zhongshan Hospital (Xiamen), Fudan University | 2026-07-01 |
| Chidamide Monotherapy for Intermediate-to-High-Risk Myelodysplastic Syndromes (NCT07616336) | Zhongshan Hospital (Xiamen), Fudan University | 2026-07-01 |
| Exploratory Clinical Trial of DQ1001 in Relapsed or Refractory Multiple Myeloma (RRMM) (NCT07622862) | Zhongshan Hospital (Xiamen), Fudan University | 2026-06-01 |
| Tegoprazan-Based Therapies for H. Pylori Eradication: A Randomized Controlled Trial (NCT06977841) | Zhongshan Hospital (Xiamen), Fudan University | 2025-06-10 |
| Epidemiological Studies and Risk Factor Analysis of GERD in Xiamen City (NCT06585176) | Zhongshan Hospital (Xiamen), Fudan University | 2024-08-01 |
| Gut Microbiome-Metabolome Profiling in H. Pylori-SIBO Comorbidity (NCT07122284) | Zhongshan Hospital (Xiamen), Fudan University | 2024-01-31 |
| Enoxaparin for Preventing the Radical Artery Occlusion After the Transradial Access Hepatic Arterial Infusion Chemotherapy (NCT06293287) | Zhongshan Hospital (Xiamen), Fudan University | 2024-01-31 |
| The Effects of High-dose Dual Therapy With Probiotics on Gut Microbiota for Helicobacter Pylori Rescue Treatment (NCT06292546) | Zhongshan Hospital (Xiamen), Fudan University | 2024-01-31 |
| Study on Screening, Verification and Intervention of High-risk Patients With Liver Cancer (NCT05721300) | Zhongshan Hospital (Xiamen), Fudan University | 2023-02-10 |